Evidence map›Paper›PMID 22035109›Full record

ArticleJournal of neurochemistry2012

Brain-derived neurotrophic factor uses CREB and Egr3 to regulate NMDA receptor levels in cortical neurons.

Julia H Kim, Daniel S Roberts, Yinghui Hu, Garrick C Lau, Amy R Brooks-Kayal, David H Farb, Shelley J Russek

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neurochemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Review
  3. Inducible CRISPR Epigenome Systems Mimic Cocaine Induced Bidirectional Regulation of Nab2 and Egr3.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Frontiers in behavioral neuroscience · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Reward Network Immediate Early Gene Expression in Mood Disorders.Frontiers in behavioral neuroscience · 2017
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Julia H KimLaboratory of Translational Epilepsy, Boston University School of Medicine, Boston, Massachusetts, USA.
Daniel S Roberts
Yinghui Hu
Garrick C Lau
Amy R Brooks-Kayal
David H Farb
Shelley J Russek
Boston University · USMetropolitan University · BDUniversity of Colorado Denver · US

Funding

TRAINING IN BIOMOLECULAR PHARMACOLOGYT32GM008541 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FARB, DAVID H · 1997 to 2022
$5.2M
Molecular Determinants of GABAA Receptor Gene RegulationR01NS050393 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI RUSSEK, SHELLEY J · 2006 to 2010
$1.8M
NIGMS NIH HHS T32 GM008541NINDS NIH HHS NS050393-010A
6 · The paper itself

Abstract

Regulation of gene expression via brain-derived neurotrophic factor (BDNF) is critical to the development of the nervous system and may well underlie cognitive performance throughout life. We now describe a mechanism by which BDNF can exert its effects on postsynaptic receptor populations that may have relevance to both the normal and diseased brain where BDNF levels either rise or fall in association with changes in excitatory neurotransmission. Increased levels of NMDA receptors (NMDARs) occur in rat cortical neurons via synthesis of new NMDA receptor 1 (NR1) subunits. The majority of synthesis is controlled by binding of cAMP response element binding protein (CREB) and early growth response factor 3 (Egr3) to the core NR1 promoter (NR1-p) region. BDNF-mediated NR1 transcription depends upon induction of the mitogen-activated protein kinase (MAPK) pathway through activation of the TrK-B receptor. Taken together with the fact that NMDAR activation stimulates BDNF synthesis, our results uncover a feed-forward gene regulatory network that may enhance excitatory neurotransmission to change neuronal behavior over time.

Indexed as

AnimalsBrain-Derived Neurotrophic FactorCells, CulturedCerebral CortexChromatin ImmunoprecipitationCREB-Binding ProteinElectrophoretic Mobility Shift AssayEmbryo, MammalianEnzyme InhibitorsEther-A-Go-Go Potassium ChannelsGene Expression RegulationHumansLuminescent ProteinsMAP Kinase Kinase KinasesNeuronsPhosphorylationBrain-Derived Neurotrophic FactorCREB-Binding ProteinEnzyme InhibitorsEther-A-Go-Go Potassium Channelsfluorescent protein 583KCNH7 protein, humanLuminescent ProteinsMAP Kinase Kinase KinasesNR1 NMDA receptorReceptors, N-Methyl-D-AspartateReceptor, trkBSerineTetradecanoylphorbol Acetate

Identifiers

PMID22035109
PMCPMC5116917
OpenAlexW1579108216

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.